1. Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer
   Carlos Vela-Rodríguez et al, 2022, Biochemical Society Transactions CrossRef
2. The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma
   Hongmei Cui et al, 2021, Frontiers in Pharmacology CrossRef